List of Excipients in API ibrexafungerp
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing ibrexafungerp
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
SCYNEXIS INC | BREXAFEMME | ibrexafungerp | 75788-115 | BUTYLATED HYDROXYANISOLE | 2035-01-19 |
SCYNEXIS INC | BREXAFEMME | ibrexafungerp | 75788-115 | CELLULOSE, MICROCRYSTALLINE | 2035-01-19 |
SCYNEXIS INC | BREXAFEMME | ibrexafungerp | 75788-115 | CROSPOVIDONE | 2035-01-19 |
SCYNEXIS INC | BREXAFEMME | ibrexafungerp | 75788-115 | FD&C BLUE NO. 2 | 2035-01-19 |
SCYNEXIS INC | BREXAFEMME | ibrexafungerp | 75788-115 | FD&C RED NO. 40 | 2035-01-19 |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for ibrexafungerp
Excipient focus: BUTYLATED HYDROXYANISOLE
ibrexafungerp drug variants containing BUTYLATED HYDROXYANISOLE
Company | Ingredient | NDC |
---|---|---|
SCYNEXIS INC | ibrexafungerp | 75788-115 |
>Company | >Ingredient | >NDC |
ibrexafungerp drug variants not containing BUTYLATED HYDROXYANISOLE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
ibrexafungerp drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
SCYNEXIS INC | ibrexafungerp | 75788-115 |
>Company | >Ingredient | >NDC |
ibrexafungerp drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
ibrexafungerp drug variants containing CROSPOVIDONE
Company | Ingredient | NDC |
---|---|---|
SCYNEXIS INC | ibrexafungerp | 75788-115 |
>Company | >Ingredient | >NDC |
ibrexafungerp drug variants not containing CROSPOVIDONE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
ibrexafungerp drug variants containing FD&C BLUE NO. 2
Company | Ingredient | NDC |
---|---|---|
SCYNEXIS INC | ibrexafungerp | 75788-115 |
>Company | >Ingredient | >NDC |
ibrexafungerp drug variants not containing FD&C BLUE NO. 2
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
ibrexafungerp drug variants containing FD&C RED NO. 40
Company | Ingredient | NDC |
---|---|---|
SCYNEXIS INC | ibrexafungerp | 75788-115 |
>Company | >Ingredient | >NDC |
ibrexafungerp drug variants not containing FD&C RED NO. 40
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
ibrexafungerp drug variants containing HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
SCYNEXIS INC | ibrexafungerp | 75788-115 |
>Company | >Ingredient | >NDC |
ibrexafungerp drug variants not containing HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
ibrexafungerp drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
SCYNEXIS INC | ibrexafungerp | 75788-115 |
>Company | >Ingredient | >NDC |
ibrexafungerp drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
ibrexafungerp drug variants containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
SCYNEXIS INC | ibrexafungerp | 75788-115 |
>Company | >Ingredient | >NDC |
ibrexafungerp drug variants not containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
ibrexafungerp drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
SCYNEXIS INC | ibrexafungerp | 75788-115 |
>Company | >Ingredient | >NDC |
ibrexafungerp drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TALC
ibrexafungerp drug variants containing TALC
Company | Ingredient | NDC |
---|---|---|
SCYNEXIS INC | ibrexafungerp | 75788-115 |
>Company | >Ingredient | >NDC |
ibrexafungerp drug variants not containing TALC
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
ibrexafungerp drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
SCYNEXIS INC | ibrexafungerp | 75788-115 |
>Company | >Ingredient | >NDC |
ibrexafungerp drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.